XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 30, 2024
Apr. 01, 2023
Operating Activities    
Net Income Attributable to Kadant $ 24,689 $ 28,075
Net income attributable to noncontrolling interests 296 184
Net Income 24,985 28,259
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 11,739 8,446
Stock-based compensation expense 2,415 2,238
Provision for losses on accounts receivable 413 13
Other items, net 803 829
Changes in assets and liabilities, net of effects of acquisitions:    
Accounts receivable (7,956) 517
Contract assets (2,425) 2,637
Inventories (6,721) (13,997)
Other assets 609 1,293
Accounts payable 15,036 77
Customer deposits (778) 11,114
Other liabilities (15,289) (4,560)
Net cash provided by operating activities 22,831 36,866
Investing Activities    
Acquisitions, net of cash acquired (Note 2) (232,261) 0
Purchases of property, plant, and equipment (6,271) (4,469)
Proceeds from sale of property, plant, and equipment 1,269 32
Other investing activities 0 (30)
Net cash used in investing activities (237,263) (4,467)
Financing Activities    
Proceeds from issuance of long-term obligations (Note 6) 234,000 0
Repayment of short- and long-term obligations (33,450) (20,761)
Tax withholding payments related to stock-based compensation (5,855) (3,897)
Dividends paid (3,395) (3,036)
Proceeds from issuance of Company common stock 1,605 0
Other financing activities 0 (63)
Net cash provided by (used in) financing activities 192,905 (27,757)
Exchange Rate Effect on Cash, Cash Equivalents, and Restricted Cash (2,308) 1,140
(Decrease) Increase in Cash, Cash Equivalents, and Restricted Cash (23,835) 5,782
Cash, Cash Equivalents, and Restricted Cash at Beginning of Period 106,453 79,725
Cash, Cash Equivalents, and Restricted Cash at End of Period $ 82,618 $ 85,507